These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 15064326)

  • 1. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels.
    Martina M; Gorfinkel Y; Halman S; Lowe JA; Periyalwar P; Schmidt CJ; Bergeron R
    J Physiol; 2004 Jun; 557(Pt 2):489-500. PubMed ID: 15064326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of glycine transporter-1 (GLYT-1) potentiates NMDA receptor-mediated synaptic transmission in hypoglossal motorneurons.
    Lim R; Hoang P; Berger AJ
    J Neurophysiol; 2004 Oct; 92(4):2530-7. PubMed ID: 15175365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
    Manahan-Vaughan D; Wildförster V; Thomsen C
    Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine-induced long-term synaptic potentiation is mediated by the glycine transporter GLYT1.
    Igartua I; Solís JM; Bustamante J
    Neuropharmacology; 2007 Jun; 52(8):1586-95. PubMed ID: 17462677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
    Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
    Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained saturating level of glycine induces changes in NR2B-containing-NMDA receptor localization in the CA1 region of the hippocampus.
    Imamura Y; Ma CL; Pabba M; Bergeron R
    J Neurochem; 2008 Jun; 105(6):2454-65. PubMed ID: 18331477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the glycine site of the N-methyl-D-aspartate receptor in synaptic plasticity induced by pairing.
    Krasteniakov NV; Martina M; Bergeron R
    Eur J Neurosci; 2005 May; 21(10):2782-92. PubMed ID: 15926925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine binding primes NMDA receptor internalization.
    Nong Y; Huang YQ; Ju W; Kalia LV; Ahmadian G; Wang YT; Salter MW
    Nature; 2003 Mar; 422(6929):302-7. PubMed ID: 12646920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic nicotine-induced switch in Src-family kinase signaling for long-term potentiation induction in hippocampal CA1 pyramidal cells.
    Yamazaki Y; Jia Y; Wong JK; Sumikawa K
    Eur J Neurosci; 2006 Dec; 24(11):3271-84. PubMed ID: 17156388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
    Suárez LM; Solís JM
    Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-serine relieves chronic lead exposure-impaired long-term potentiation in the CA1 region of the rat hippocampus in vitro.
    Sun H; Wang HL; Wang S
    Neurosci Lett; 2007 May; 417(2):118-22. PubMed ID: 17408856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthreshold contribution of N-methyl-d-aspartate receptors to long-term potentiation induced by low-frequency pairing in rat hippocampal CA1 pyramidal cells.
    Krasteniakov NV; Martina M; Bergeron R
    Neuroscience; 2004; 126(1):83-94. PubMed ID: 15145075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity.
    Liu L; Wong TP; Pozza MF; Lingenhoehl K; Wang Y; Sheng M; Auberson YP; Wang YT
    Science; 2004 May; 304(5673):1021-4. PubMed ID: 15143284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NR2A-containing NMDA receptors are required for LTP induction in rat dorsolateral striatum in vitro.
    Li P; Li YH; Han TZ
    Brain Res; 2009 Jun; 1274():40-6. PubMed ID: 19376094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.
    Nomura I; Kato N; Kita T; Takechi H
    Neurosci Lett; 2005 Dec; 391(1-2):1-6. PubMed ID: 16154266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons.
    Martina M; Krasteniakov NV; Bergeron R
    J Physiol; 2003 Apr; 548(Pt 2):411-23. PubMed ID: 12611916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic DHEAS administration facilitates hippocampal long-term potentiation via an amplification of Src-dependent NMDA receptor signaling.
    Chen L; Miyamoto Y; Furuya K; Dai XN; Mori N; Sokabe M
    Neuropharmacology; 2006 Sep; 51(3):659-70. PubMed ID: 16806295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficit of NMDA receptor activation in CA1 hippocampal area of aged rats is rescued by D-cycloserine.
    Billard JM; Rouaud E
    Eur J Neurosci; 2007 Apr; 25(8):2260-8. PubMed ID: 17445224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.